Entries by Organicell

Organicell Announces Positive Results of Initial COVID-19 Zofin™ Patient Trial in India and Trial Expansion

Miami, FL (April 28, 2021) – Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced positive results for the first ten COVID-19 patients treated with Zofin™ in India.  This initial trial is being conducted in conjunction with Organicell’s Indian partner, CWI India, with whom Organicell […]

Organicell Completes Enrollment for its Expanded Access Trial to Treat COVID-19 Patients with Zofin™

Miami, FL (April 22, 2021) — Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the company has completed enrollment for its U.S. Food and Drug Administration (FDA) granted expanded access trial for Zofin for the treatment of COVID-19. The expanded access protocol provided […]

Organicell Announces FDA Approval Of IND Application For The Use Of Zofin™ In The Treatment Of Osteoarthritis

Miami, FL (April 21, 2021) — Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced today that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for its lead product, Zofin™, in the treatment of knee osteoarthritis. This approved trial design, […]

Organicell and Oklahoma State University Enter Into Agreement To Study Zofin™ in Respiratory Diseases Caused By Virus Infections Of Pandemic Potential

Miami, FL (April 14, 2021) – Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that it has entered into an agreement with Oklahoma State University to evaluate ZofinTM for the treatment of respiratory diseases caused by virus infections of pandemic potential. This study site […]

DR. MARI MITRANI – ORGANICELL CSO, JOINS ‘THE NICHE POD’ TO TALK ABOUT ZOFIN™ AND MUCH MORE

Dr. Mitrani talks about her journey to regenerative medicine, Organicell’s lead therapeutic Zofin™, pivoting during COVID-19, and so much more during her conversation with Noah Goodson of the Niche Experience Podcast. Click the link to listen to the full episode https://www.buzzsprout.com/1206026/8076645-the-niche-episode-037-february-bonus-interview-with-dr-mitrani-cso-at-organicell

Organicell and The Centers for Disease Control and Prevention Enter Into Agreement To Conduct Research on Influenza Viruses of Pandemic Potential

Miami, FL (March 23rd, 2021) – Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced that it has entered into a Material Cooperative Research and Development Agreement with the Centers for Disease Control and Prevention (“CDC”) to determine the anti-inflammatory and anti-infective effectiveness of Zofin™ […]

Frontiers in Medicine’ Publishes Organicell’s Case Report Demonstrating the Use of Zofin™ in the Treatment of COVID-19 Patients

Miami, FL (March 18th, 2021) – Organicell Regenerative Medicine, Inc. (OTCMKTS: BPSR), a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, today announced the publication of a peer-reviewed case report analyzing the clinical outcomes of Zofin treatment in three critically ill patients suffering from severe, multi-organ complications induced by COVID-19 infection. The report […]

ORGANICELL CSO DR. MARI MITRANI TALKS ABOUT THE DEVASTATING EFFECTS OF COVID-19 LONG HAULER SYNDROME ON ‘RPHEALTHCAST PODCAST’ PRESENTED BY ROONEY PARTNERS

Organicell CSO Dr. Mari Mitrani joined The RPHealthCast podcast presented by RooneyPartners LLC. In this season two premiere, host Jeffrey Freedman discusses the devastating effects of COVID-19 Long Hauler syndrome with a triad of medical experts; Natalie Lambert, Dr. Mari Mitrani and Heather Mackenzie Click the link to listen to the full episodehttps://open.spotify.com/episode/4oxB047zST3GDoZO37hu8N ⁠